PatientsLikeMe ™

MS
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


What is Methotrexate? Methotrexate is an antineoplastic drug used in the treatment of cancer. Also used as an antirheumatic for rheumatoid arthritis. Off label use in treatment of Crohn's disease and ectopic pregnancy. Experimental use in MS. It is given as an IM or SC injection, via IV or intrathecally.

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

49 patients in the community are taking or have taken Methotrexate.

Reason # Patients Percentage of patients
Slow my MS progress 28 65%
Other 10 23%
Pain 4 9%
Depression 1 2%

Dosages

Based on the patients currently taking Methotrexate.

Top 10 (Show all)

All (Show Top 10)

  0 none 0.8 mg week 3 mg week 3.5 mg week 7.5 mg week 10 mg week 15 mg week 17 mg week 17.5 mg week 18 mg week 20 mg week 22.5 mg week 25 mg week 10 mg day
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Methotrexate or how long patients were taking Methotrexate before stopping.

Currently taking Methotrexate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
4
3
6
13

Stopped taking Methotrexate

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
2
1
4
Why Patients Stopped Taking Methotrexate (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 3 38% Did not seem to work: 38%
Side effects too severe 2 25% Side effects too severe: 25%
Course of treatment ended 2 25% Course of treatment ended: 25%
Doctor's advice 1 13% Doctor's advice: 13%
Other 1 13% Other: 13%


Back to top